A detailed history of British Columbia Investment Management Corp transactions in Bio Techne Corp stock. As of the latest transaction made, British Columbia Investment Management Corp holds 26,307 shares of TECH stock, worth $1.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
26,307
Previous 30,122 12.67%
Holding current value
$1.97 Million
Previous $2.16 Million 2.59%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$70.96 - $82.35 $270,712 - $314,165
-3,815 Reduced 12.67%
26,307 $2.1 Million
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $706,366 - $956,869
11,371 Added 60.64%
30,122 $2.16 Million
Q1 2024

May 14, 2024

BUY
$65.98 - $77.09 $35,893 - $41,936
544 Added 2.99%
18,751 $1.32 Million
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $212,852 - $315,148
4,029 Added 28.42%
18,207 $1.4 Million
Q2 2023

Aug 11, 2023

BUY
$73.76 - $85.98 $26,553 - $30,952
360 Added 2.61%
14,178 $1.16 Million
Q4 2022

Feb 10, 2023

BUY
$80.67 - $352.29 $803,634 - $3.51 Million
9,962 Added 258.35%
13,818 $1.15 Million
Q3 2022

Nov 10, 2022

SELL
$282.54 - $391.85 $194,387 - $269,592
-688 Reduced 15.14%
3,856 $1.1 Million
Q2 2022

Aug 12, 2022

SELL
$322.67 - $449.65 $491,103 - $684,367
-1,522 Reduced 25.09%
4,544 $1.58 Million
Q1 2022

May 12, 2022

SELL
$353.85 - $487.79 $278,479 - $383,890
-787 Reduced 11.48%
6,066 $2.63 Million
Q4 2021

Feb 11, 2022

SELL
$456.15 - $525.06 $159,652 - $183,770
-350 Reduced 4.86%
6,853 $3.55 Million
Q3 2021

Nov 12, 2021

SELL
$444.87 - $538.88 $18,684 - $22,632
-42 Reduced 0.58%
7,203 $3.49 Million
Q2 2021

Aug 09, 2021

BUY
$387.35 - $450.26 $2.81 Million - $3.26 Million
7,245 New
7,245 $3.26 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.94B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.